HCA Healthcare Inc

HCA Healthcare Inc

HCA

Get informed when a big investor buys or sells

+ Follow
Market Cap$84.78B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
HCA Healthcare IncHCA Healthcare Inc13.10.78%-1.2-

Earnings Call Q2 2026

July 24, 2026 - AI Summary

EPS momentum despite headwinds (good): - HCA reported solid diluted EPS growth of ~11% in Q2 and ~11% YTD. - The company emphasized continued high-quality care while managing through policy-driven utilization and coverage changes.
Primary driver of pressure: Exchange coverage loss → payer mix deterioration (bad/surprising): - Exchange volumes declined ~15% in the first half; admissions for people formerly covered by exchanges were down ~15%. - Key surprise vs prior assumptions: instead of a partial shift away from hospital use, those losing exchange coverage migrated ~1-for-1 to uninsured (management states this explains ~80% of uninsured volume growth). - This payer mix shift created an ~$400M unfavorable impact to adjusted EBITDA in Q2 (includes +$75M related to updated Q1 estimate).
Guidance updated for exchange headwinds + Medicaid supplemental benefits (forecast/outlook): - 2026 guidance (revised): - Revenue: $77.0B to $79.5B - Adjusted EBITDA: $15.4B to $16.1B - Net income attributable to HCA: $6.3B to $6.7B - Diluted EPS: $28.70 to $30.50 - Exchange impact on adjusted EBITDA (updated): negative ~$1.0B to ~$1.2B (worsened because migration is closer to 1-for-1 to uninsured vs earlier ~80–85% assumption). - Medicaid supplemental payments (Florida-focused) net benefit: +$300M to +$500M; mgmt’s updated view implies back-half headwind of ~$100M to $300M due to timing/retro payment patterns exceeding incremental benefit later in 2026.

Exclusive for Stockcircle Pro members

Sign upSign Up
$470.89

Target Price by Analysts

20.9% upsideHCA Healthcare Target Price DetailsTarget Price
$337.16

Current Fair Value

13.5% downside

Overvalued by 13.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$84.78 Billion
Enterprise Value$94.26 Billion
Dividend Yield$3.00 (0.78%)
Earnings per Share$28.62
Beta1.13
Outstanding Shares226,653,000

Return

Return on EquityNaN%ROE
Return on Assets0.27%
Return on Invested Capital6.17%

Valuation & Multiples

P/E Ratio13.07P/E Ratio
PEG2103.68PEG
Price to Sales1.16Price to Sales
Price to Book Ratio0.91Price to Book Ratio
Enterprise Value to Revenue1.23
Enterprise Value to EBIT18.7
Enterprise Value to Net Income359
Total Debt to Enterprise0.11
Debt to Equity-Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 24, 2026
EPS Estimate
$7.56
Average shareholder expectation
Revenue Estimate
$19.76 B
Average shareholder expectation

Next Earnings Call

Expected Date
October 23, 2026
EPS Estimate
$7.07
Average shareholder expectation
Revenue Estimate
$19.52 B
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 90.89%
Total Calls-▼ 100.00%
Total Puts2,000▼ 99.78%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %2.05%▼ 54.83%
Total Invested$1.81B▼ 97.08%
Investors Holding344▼ 1126.00%

ESG Score

No data

About HCA Healthcare Inc

280,000 employees
CEO: Samuel Hazen

Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising more than 2,000 sites of care, including 187 hospitals, surgery centers, freestanding ERs, urgent care centers, and physician clini...

Relevant Senate Committees

Finance

This is one of the most powerful committees for HCA. It controls taxation (corporate tax policy directly impacts HCA's profitability) and entitlement spending, specifically overseeing Medicare and Medicaid financing, reimbursement rates, and broader healthcare spending, which are crucial revenue streams for HCA.

Appropriations

This committee directly allocates discretionary federal spending. Its subcommittees determine the precise funding for federal healthcare programs (e.g., specific allocations to HHS for Medicare/Medicaid), which are massive revenue sources for HCA Healthcare.

Health, Education, Labor, and Pensions

This committee directly impacts HCA. Its jurisdiction over health policy (FDA, NIH), labor laws (minimum wage, union regulations, workforce costs for a major employer), and pension rules directly regulates HCA's operational costs, patient care standards, and business environment.

Judiciary

This committee's oversight of antitrust laws and the DOJ is critically relevant for HCA Healthcare. As a large hospital system, HCA is frequently involved in mergers and acquisitions, making antitrust scrutiny a direct and significant factor in its growth strategy and legal environment.